Close Menu

NEW YORK (GenomeWeb) – Thermo Fisher Scientific today reported that its first quarter revenues increased 10 percent in a quarter that included four extra days compared to the prior year period.

For the three months ended April 2, Thermo Fisher reported revenue of $4.29 billion, up from $3.92 billion in the first quarter of 2015, and beating the average analyst estimate of $4.11 billion. Organic revenue grew 10 percent while acquisitions increased revenue by 1 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.